InstantLabs Places Beta Units of POC Testing Platform; Eyes Trials for MRSA Test in 2011 | GenomeWeb

This article has been updated from a previous version to correct the spelling of InstantLabs' commercial partner Biolyph and clarify information about the Hunter platform.

By Ben Butkus

InstantLabs, a Reston, Va.-based firm founded in 2008 to commercialize a portable, point-of-need real-time PCR-based molecular testing platform, said this week that it has placed 20 beta versions of its instrument worldwide, primarily for food safety and product verification applications.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.